Background
==========

The World Health Organization (WHO) estimates that at least 16% of maternal deaths in low- and middle-income countries result from hypertensive disorders of pregnancy, including severe pre-eclampsia and eclampsia (PE/E) [\[]{.smallcaps}\[[@B1]\][\]]{.smallcaps}. Clinical indications of pre-eclampsia typically present as high blood pressure and protein in the urine after 20 weeks gestation. Eclampsia is diagnosed when a pregnant woman with pre-eclampsia develops convulsions \[[@B2]\]. Although there are known risk factors for hypertensive disorders of pregnancy, there is no clinically useful way to predict which women will develop pre-eclampsia based on clinical data or biochemical markers \[[@B3]\]. However, high-income countries have been able to reduce both the incidence of eclampsia and the case fatality rate associated with it by 90%, using a combination of early detection during antenatal care (ANC) and increased access to hospital care for women who develop severe PE/E \[[@B4]\]. Comparable reductions in rural China and Sri Lanka suggest that this model---which includes routinely screening pregnant women for hypertension and proteinuria, treating severe PE/E with anti-hypertensive and anticonvulsant drugs, and, if necessary, ending the pregnancy early by inducing labor or conducting cesarean delivery---can be applied in low-income countries \[[@B5]\].

Implementing this strategy in a low-resource setting is challenging, however. First, it requires good quality focused ANC for all pregnant women in order to detect cases of severe PE/E, along with increased awareness of danger signs among women and the community. Since PE/E can occur during pregnancy, labor, or postpartum, it is important that detection efforts begin in pregnancy and continue through labor and the postpartum period. Second, it demands the presence of skilled birth attendants at antenatal clinics and during births, with ready access to emergency obstetric and newborn care (EmONC). Managing eclampsia with anticonvulsants is one of nine essential EmONC services---called signal functions---that directly prevent and/or treat complications associated with maternal and newborn death. Indeed, routine screening only makes sense when women diagnosed with severe pre-eclampsia can be referred to EmONC facilities that have skilled personnel, supplies, and equipment needed to treat the condition and induce labor \[[@B6]\]. Finally, addressing severe PE/E requires adequate and reliable supplies of equipment and drugs---to measure blood pressure, test for proteinuria, and treat PE/E---at every level of the health system \[[@B4]\]. Magnesium sulfate (MgSO~4)~ is critical, because it is the drug of choice for preventing convulsions in pre-eclamptic women and for preventing recurrence of convulsions \[[@B7]\]. Multi-center trials have demonstrated that this anticonvulsant, which is inexpensive and does not require special storage, is significantly more effective than diazepam or other drugs in reducing convulsions, preventing progression from severe pre-eclampsia to eclampsia, and improving outcomes for mothers and newborns \[[@B8]-[@B10]\].

In Afghanistan---where the maternal mortality ratio is high at 327 deaths per 100,000 live births and hypertensive disorders of pregnancy account for 20% of maternal deaths \[[@B11]\]---reducing morbidity and mortality from severe PE/E will require systematic changes in women's health-seeking behaviors and access to health care, as well as an increase in the capacity of the health system to offer ANC and EmONC services. In a recent national survey, just 48% of Afghan women (77% in urban areas and 41% in rural areas) reported receiving ANC from a skilled provider and only 15% made at least four ANC visits, as recommended by WHO \[[@B12]\]. According to women's reports, ANC providers were not likely to measure blood pressure or take urine samples (35% and 24%, respectively). Only one-third of Afghan women delivered in health facilities (66% urban, 25% rural), and 39% were attended by skilled providers (74% urban, 31% rural).

In Afghanistan's tiered health system, health posts, basic health centers, and comprehensive health centers (CHCs) offer basic curative and preventive services at the community level. The district hospital (or CHC where no district hospital exists) serves as the link between primary care facilities and the network of referral hospitals. The sophistication level of health infrastructure and services increases from district hospitals to provincial and regional hospitals to national specialty hospitals. The Ministry of Public Health of Afghanistan (MoPH) has designated 127 health facilities to provide comprehensive EmONC services, including all district, provincial, and regional hospitals, as well as national hospitals specializing in maternity care and certain CHCs in remote areas.

This study examines one part of the strategy to reduce morbidity and mortality from PE/E in Afghanistan: improving the treatment of severe PE/E. We performed a further analysis of the 2009--10 Afghanistan Emergency Obstetric and Newborn Care Needs Assessment \[[@B13]\] to evaluate the capacity of EmONC facilities and their providers to manage severe PE/E cases.

Methods
=======

In 2009--10, a needs assessment sought to examine EmONC services at all 127 designated EmONC facilities; however, 49 of those facilities (16 CHCs, 25 district hospitals, five provincial hospitals and three national specialty hospitals) were not accessible due to security constraints \[[@B14]\]. The remaining 78 facilities constitute the study sample. They include nine CHCs, 34 district hospitals, 25 provincial hospitals, five regional hospitals, and five national specialty hospitals. Two-thirds of the facilities are located in urban areas. Although the study covered only 61% of the government health facilities expected to provide comprehensive EmONC services, it included facilities in 31 of Afghanistan's 34 provinces and assessed all facilities in secure areas where it is possible for international nongovernmental organizations (NGOs) to implement health programs and conduct research. Two doctors and two midwives responsible for providing EmONC services were randomly selected to participate in the study at each provincial, regional, and specialty hospital. Two providers, including a doctor if one was available, were chosen to participate at each district hospital and CHC.

The assessment team consisted of six doctors and 38 midwives. All were experienced service providers and had helped collect data for previous studies in Afghanistan. The assessors had one week of training, after which intra- and inter-assessor reliability were tested. They visited each facility for one to three days to collect data. Health facilities were not informed in advance about the assessors' visit. Upon arrival at each facility, assessors obtained consent from the facility's Medical Director and held an introductory meeting with key informants, including staff in charge of maternity, surgery, pharmacy, and laboratory departments.

To investigate the facility's capacity to provide ANC, labor, and delivery services, assessors made observations, interviewed key informants, and reviewed records, using tools based on a Needs Assessment Toolkit developed by the Averting Maternal Death and Disability (AMDD) Program \[[@B15]\]. Assessors also interviewed providers regarding their training on and experience with focused ANC and treatment of severe PE/E. A written case scenario was used to evaluate providers' knowledge and clinical judgment regarding severe PE/E. The case scenario described a pregnant woman brought to the emergency department of a district hospital after experiencing convulsions at home. At each step in the scenario, providers were asked how the case should be managed; they selected appropriate actions from a list of possible options. The percentage of providers who selected each correct response was calculated. The case scenario instrument shows exactly what background information was given to providers, along with the questions and a list of all possible answers \[see Additional file [1](#S1){ref-type="supplementary-material"}\].

The MoPH and National Reproductive Health Task Force adapted AMDD observation, interview, and record review tools for use in this study. They then led a workshop to review and revise the tools with national EmONC trainers and experts from UNICEF, WHO, and NGOs contracted by the MoPH to operate primary health facilities. The PE/E case scenario was developed separately by international experts at the Maternal and Child Health Integrated Program (MCHIP). All tools, including the case scenario, were pilot tested in Afghanistan during the assessors' training workshop. The study protocols were approved by the Institutional Review Boards of the Afghanistan Public Health Institute and the Johns Hopkins School of Public Health (IRB 2333 and IRB 2359).

Descriptive statistics were used to summarize facility and provider characteristics. Student t-test, one-way ANOVA, and chi-square tests were performed to determine whether there were significant differences between types of facilities, doctors and midwives, and trained and untrained providers. Analyses were conducted using STATA 11.2 with a type 1 error of 0.05.

Results
=======

Caseloads, supplies, and drugs
------------------------------

The number of women with severe PE/E treated at EmONC facilities varied widely. The median number of severe PE/E cases in the past year was just 5 (range 0--42) at CHCs and district hospitals, compared with 44 (range 0--130) at provincial hospitals and 108 (32--540) at regional and specialized hospitals (p \< 0.001) (Table [1](#T1){ref-type="table"}). This reflects variations in the size and caseload at different types of EmONC facilities: the median number of vaginal deliveries documented in maternity ward logbooks ranged from 1,078 (range 76--7,002) deliveries per year at CHCs and district hospitals to 7,516 (range 920--43,772) at provincial hospitals and 35,182 (range 6,368--82,124) at regional and specialized hospitals.

###### 

PE/E caseload, supplies, and equipment at health facilities, by facility type

  **Item**                                                                                   **CHCs and district hospitals (n = 43)**   **Provincial hospitals (n = 25)**   **Regional and specialized hospitals (n = 10)**   **p-value**
  ----------------------------------------------------------------------------------------- ------------------------------------------ ----------------------------------- ------------------------------------------------- -------------
  **No. of vaginal deliveries in last 12 months**                                                                                                                                                                                   
   Median                                                                                                     1,078                                   7,516                                     35,182                          \<0.001
   Range                                                                                                    76--7,002                              920--43,772                               6,368--82,124                          
  **No. of PE/E cases in last 12 months**                                                                                                                                                                                           
   Median                                                                                                       5                                      44                                         108                           \<0.001
   Range                                                                                                      0--42                                  0--130                                     32--540                             
  **At least one PE/E case treated in past 3 months (%)**                                                      72.1                                   100.0                                      100.0                           0.003
  **Guidelines present in maternity ward (%)**                                                                                                                                                                                      
   Focused ANC                                                                                                 88.4                                   92.0                                       100.0                           0.500
   Management of obstetric complications                                                                       83.7                                   88.0                                       100.0                           0.378
  **Supplies and equipment available (%)**                                                                                                                                                                                          
   BP cuff and stethoscope                                                                                    100.0                                   100.0                                      100.0                           1.000
   Urine test strips                                                                                           62.8                                   64.0                                       60.0                            1.000
   Complete IV set^a^                                                                                          76.7                                   96.0                                       80.0                            0.088
  **Any anti-hypertensive available (%)**^**b**^                                                               95.4                                   88.0                                       100.0                           0.404
  **Anticonvulsants available (%)**                                                                                                                                                                                                 
   MgSO~4~                                                                                                     93.0                                   96.0                                       100.0                           1.000
   Diazepam                                                                                                    90.7                                   96.0                                       70.0                            0.090
  **Among facilities that administered anticonvulsants in last 3 months, drugs (%) used**                   *(n = 33)*                             *(n = 25)*                                 *(n = 10)*                            
   MgSO~4~ only                                                                                                66.6                                   40.0                                       50.0                            0.449
   Diazepam only                                                                                                0                                      4.0                                         0                                
   Both drugs                                                                                                  33.3                                   56.0                                       50.0                               

^a^Includes IV cannulae, catheter for IV line, and IV infusion stand.

^b^Hydralazine, methyldopa, and/or nefedipine.

On the day of the survey, pertinent service delivery guidelines were available in 83.7% to 100% of facilities (Table [1](#T1){ref-type="table"}). Blood pressure cuffs and stethoscopes were available at all facilities, and three-fifths had urine test strips to check for proteinuria. From 76.7% to 96% of facilities had a complete IV set to maintain fluid balance and administer anti-hypertensives and MgSO~4.~ There were no significant differences in the availability of any of these items by facility type. All but one CHC, one district hospital, and three provincial hospitals had anti-hypertensive drugs in stock.

Anticonvulsants were widely available, although not always used. MgSO~4~ was in stock at all regional and specialized hospitals and over 93% of other facilities. Diazepam was almost as widely available, except at regional and specialized hospitals. With one exception, all facilities had administered the preferred anticonvulsant, MgSO~4.~ However, 33% of CHCs and district hospitals, 56% of provincial hospitals, and 50% of regional and specialized hospitals had administered diazepam in some cases as well. Only one facility (a provincial hospital) reported administering diazepam but not MgSO~4.~ Of the 10 CHCs and district hospitals that had not recently administered anticonvulsants, six reported that no women had required it and three did not give any reason. Lack of supplies and equipment, training issues, and availability of human resources were additional reasons given for not administering anticonvulsants.

Provider experience and training
--------------------------------

Fewer doctors than midwives participated in the study (82 and 142, respectively), but all were female, by cultural preference. Only a small proportion of the providers (27% of doctors and 14% of midwives) worked at large regional and specialized hospitals (Table [2](#T2){ref-type="table"}). The median years of experience offering EmONC services was five years for doctors and four years for midwives; their training, experience, and confidence levels in providing focused ANC were also similar.

###### 

Providers' workplace, experience, and training, by provider type

                                                                                     **Doctors (n = 82)**   **Midwives (n = 142)**   **p-value**
  --------------------------------------------------------------------------------- ---------------------- ------------------------ -------------
                              **Location of work (%)**                                                                                     
                               CHC or district hospital                                      30.4                    44.5               0.079
                                 Provincial hospital                                         43.0                    41.6           
                      Regional hospital or specialized hospital                              26.5                    13.9           
               **Years of experience offering EmONC: median (range)**                     5 (1--22)               4 (1--32)             0.781
                                   **Focused ANC**                                                                                         
                               Has received training (%)                                     77.6                    81.2               0.430
           Number of cases attended in last 3 months: median (range)^**a**^              60 (0--900)             100 (0--855)          0.0903
                           Confidence in providing care (%):                                                                               
                                    Very confident                                           86.7                    87.4               0.896
                         Somewhat confident (needs coaching)                                 12.0                    11.1           
                                    Not confident                                            1.3                     1.5            
                            **Treatment of severe PE/E**                                                                                   
                         Has received training on MgSO~4~ (%)                                82.1                    78.6               0.714
     Number of cases given anticonvulsants in last 3 months: median (range)^**a**^        5 (0--65)               3 (0--50)             0.031
                   Confidence in administering anticonvulsants (%):                                                                        
                                    Very confident                                           83.1                    79.2               0.01
                         Somewhat confident (needs coaching)                                 8.5                     16.0           
                                    Not confident                                            8.5                     4.8            

^a^n = 76 doctors and 135 midwives for number of cases attended in last 3 months.

There was no significant difference in the proportion of doctors and midwives who had received in-service training on the use of MgSO~4~ to treat severe PE/E (82% and 79%). Doctors had administered anticonvulsants to significantly more women than the midwives had, on average, in the preceding three months (median of five and three women, respectively). However, individual providers had widely varying experience with anticonvulsants: the number of women to whom they had given anticonvulsants in the past three months ranged from a low of zero to a high of 65. Providers' confidence in their ability to administer anticonvulsants was generally high: 83% of doctors and 79% of midwives said they felt very confident. However, almost twice as many midwives as doctors (16% versus 8.5%, p \< 0.01) expressed some reservations, saying they were in need of coaching.

Case management
---------------

Providers' knowledge and decision-making skills related to severe PE/E were tested with a case scenario describing a pregnant woman who came to the emergency department after having convulsions at home. Each part of the scenario is described in detail below.

Part one asked providers what information must be obtained *immediately* in order to initiate emergency management of the woman's most urgent condition. A large majority of doctors and midwives (from 83.6% to 96.9%) correctly identified three pieces of information on the woman's status: vital signs, level of consciousness, and presence of current convulsions (Table [3](#T3){ref-type="table"}). There were no significant differences by provider type. Knowledge was significantly higher among providers who had received training on MgSO~4~ compared to untrained providers for presence of current convulsions (69.4% versus 90.5%, p \< 0.001). Knowledge on level of consciousness was significantly lower at CHCs and district hospitals than at provincial hospitals or at regional and specialized hospitals (80.3% versus 93.3% and 90.9%, p \< 0.05).

###### 

Case management: percentage of providers responding correctly to case scenario related to severe pe/e symptoms, by provider type, provider training, and facility type

                                                                                 **Provider type**   **Provider training**   **Facility type**                                                
  ----------------------------------------------------------------------------- ------------------- ----------------------- ------------------- ------- ------ --------- ------ ------ ------ -------
     **I. Information needed immediately to start emergency management (%)**                                                                                                                  
                             Level of consciousness                                    92.2                  83.6                  0.228         80.0    89.7    0.076    80.3   93.3   90.9   0.046
                         Presence of current convulsions                               88.4                  87.3                  0.949         69.4    90.5   \<0.001   80.0   92.3   91.1   0.082
                                   Vital signs                                         96.9                  96.4                  0.929         100.0   95.8    0.214    97.0   96.3   97.0   0.970
                       **II. Diagnosis of eclampsia (%)**                                                                                                                                     
                             Diagnosis of eclampsia                                    77.2                  62.3                  0.120         66.7    67.8    1.000    60.5   66.3   81.1   0.282
           **III. Urgent actions to manage presenting condition (%)**                                                                                                                         
                                   Bed rest^a^                                         44.3                  42.5                  0.725         58.3    38.2    0.019    31.4   53.7   50.0   0.008
                                     MgSO~4~                                           96.2                  88.5                  0.051         82.3    93.3    0.035    87.2   92.6   94.7   0.297
   **IV. Immediate actions if woman is having convulsions when admitted (%)**                                                                                                                 
                         Give oxygen at 4--6 L per min.                                88.6                  81.3                  0.153         83.3    86.0    0.638    79.1   85.3   92.1   0.171
                          Place in side-lying position                                 88.6                  85.6                  0.622         77.1    87.6    0.098    83.7   92.6   78.9   0.062
                            Protect woman from injury                                  79.2                  75.0                  0.696         75.0    75.8    1.000    68.6   78.9   86.8   0.064
   **V. Essential equipment and supplies to manage most urgent condition (%)**                                                                                                                
                        IV with saline or Ringers Lactate                              78.4                  87.7                  0.070         83.3    83.7    0.823    83.7   86.3   76.3   0.372
                        Indwelling urinary catheter/ bag                               87.0                  83.1                  0.361         85.4    82.6    0.830    74.4   90.5   89.4   0.008
                          Suction and suction catheter                                 87.3                  78.2                  0.098         68.8    76.4    0.335    68.6   87.4   92.1   0.001
                              Oxygen and adult mask                                    91.1                  84.2                  0.142         77.1    88.8    0.049    82.6   87.4   86.8   0.633
        **VI. Appropriate actions after convulsions are controlled (%)**                                                                                                                      
                        Repeat dose of MgSO~4~ in 4 hours                              71.4                  77.9                  0.301         64.6    77.5    0.083    74.4   73.7   84.2   0.409
                           Continue anti-hypertensives                                 81.0                  66.2                  0.024         56.3    74.7    0.016    70.9   67.4   81.6   0.072
                         Monitor labor, begin partograph                               79.2                  80.9                  0.532         77.3    81.4    0.672    72.1   89.5   79.0   0.262
             Check respirations hourly (auscultate lungs if needed)                    59.5                  54.7                  0.683         35.4    61.8    0.002    50.0   62.1   60.1   0.012
                          Document intake/output hourly                                75.9                  69.1                  0.269         68.8    71.4    0.854    62.8   76.8   73.7   0.232
             **VII. Appropriate actions after vaginal delivery (%)**                                                                                                                          
                          Continue MgSO~4~ for 24 hours                                80.5                  77.2                  0.995         72.7    80.8    0.302    72.1   83.2   84.2   0.130
           Assess vital signs every 15 minutes for 2 hours after birth                 90.9                  90.4                  0.652         88.6    91.6    0.771    91.9   92.6   84.2   0.288

^a^Bed rest is interpreted as continuous care in a bed near staff until she is stable, with hourly observations thereafter.

Part two asked providers to diagnose the woman's condition based on the results of a clinical exam. The correct answer, eclampsia, was given by 77.2% of doctors and 62.3% of midwives. All but two of the remaining providers diagnosed pre-eclampsia instead. There were no significant differences in diagnosis by provider type, training, or facility type.

Part three asked providers to select appropriate actions to manage the most urgent presenting condition. A large majority (96.2% of doctors and 88.5% of midwives) recognized the need to give MgSO~4~, but less than half (44.3% of doctors and 42.5% of midwives) noted the need for continuous bedside care until the woman is stable with hourly observations thereafter. Providers trained on the use of MgSO~4~ were significantly more likely than others to identify the need for the drug (93.3% versus 82.3%, p \< 0.05), but were less likely to select continuous bedside care followed by hourly observations (58.3% versus 38.2%, p \< 0.05). Providers working at CHCs and district hospitals were significantly less likely than providers at larger facilities to recognize the need for bed rest (31.4% versus 53.7% and 50%, p \< 0.01).

Part four asked what immediate actions providers should take if a woman had a convulsion at the time of admission. Over four-fifths of providers (81.3% to 88.6%) said to administer oxygen and to place the woman in a side-lying position; slightly fewer (75% to 79.2%) said to protect the woman from injury. There were no significant differences by provider type, training, or facility type. Notably, around half of providers (42% of doctors and 58% of midwives, p \< 0.05) mentioned the need for intravenous diazepam, a second-line drug recommended only in the absence of MgSO~4~; there was no significant difference by facility type (data not shown). Providers who received training on MgSO~4~ were less likely than other providers to call for giving diazepam (38% versus 53%), but the difference was not statistically significant.

Part five asked providers which equipment and supplies must be available to best manage the woman's most urgent condition. A large majority (from 78% to 91%) correctly identified an IV line, urinary catheter, suction catheter, and oxygen. There was no significant difference between doctors and midwives, but providers trained on MgSO~4~ were significantly more likely than others to identify oxygen and an adult mask (89% versus 77%, p \< 0.05). Providers working at CHCs and district hospitals were significantly less likely than those at larger facilities to identify urinary catheters (74.4% versus 90.5% and 89.4%, p \< 0.01) and suction catheters (68.6% versus 87.4% and 92.1%, p \< 0.001). Many providers (39% of doctors and 55% of midwives) also believed that it was essential to have equipment available to administer intravenous diazepam, and there was no significant difference by facility type or provider training (data not shown).

Part six asked providers what actions were appropriate one hour following the initiation of treatment if the woman still had a moderate headache but no further convulsions. From 55% to 81% of providers identified each of the five correct responses. Doctors were significantly more likely than midwives to recognize the need to continue use of anti-hypertensives to maintain diastolic blood pressure between 90--100 mm Hg (81% versus 66.2%, p \< 0.05). Trained providers were significantly more likely than others to identify continued use of anti-hypertensives (74.7% versus 56.3%, p \< 0.05) and checked respirations every hour, auscultating the lungs if necessary (35.4% versus 61.8%, p \< 0.001). Regularly checking the respiratory rate is especially important because most health facilities in Afghanistan lack oximeters to check oxygen saturation.

The final part of the scenario asked providers what actions were appropriate after the woman had a spontaneous vaginal delivery. A large majority of providers recognized the need to continue MgSO~4~ for 24 hours after birth (80.5% of doctors and 77.2% of midwives) and assess vital signs every 15 minutes during the first two hours after birth (90.9% of doctors and 90.4% of midwives). There were no significant differences by provider type, facility type, or provider training.

Overall, providers who had been trained on the treatment of severe PE/E scored significantly higher than untrained providers on six out of 20 items in the case scenario. There were significant differences by facility type for five out of the 20 items; providers at CHCs and district hospitals scored lower than providers at larger hospitals. Finally, there was a significant difference between doctors and midwives on just one item: continued use of anti-hypertensives after convulsions are controlled.

Discussion
==========

Most women in Afghanistan deliver at home and must overcome long distances, difficult terrain, poor roads, and limited transportation to get to health facilities if they suffer complications \[[@B16]\]. It is essential that providers have the knowledge, skills, supplies, and equipment needed to immediately diagnose and address complications. Our findings show that most EmONC facilities and providers in Afghanistan are relatively well-prepared to manage severe PE/E cases, but certain weaknesses need to be addressed.

Managing hypertension and preventing convulsions are key elements in treating severe PE/E. All assessed facilities had blood pressure cuffs and stethoscopes on hand, and a large majority had anti-hypertensive drugs in stock. However, the case scenario found that about one-fifth of doctors and one-third of midwives did not correctly identify the need to continue administering anti-hypertensives after delivery in cases of PE/E. This finding suggests that a substantial portion of women with PE/E may not be treated for hypertension after delivery.

While any of several anti-hypertensive drugs may be used to treat severe PE/E \[[@B7]\], MgSO~4~ is the clear drug of choice to prevent convulsions, and its potential impact on maternal morbidity and mortality is considerable. In Nigeria, for example, the case fatality rate for severe PE/E at hospitals in Kano fell from 20.9% to 2.3% after MgSO~4~ was introduced; perinatal mortality also fell significantly \[[@B17]\]. The drug has been identified in a list of 13 affordable, effective, but underutilized lifesaving commodities by the United Nations Commission on Life-Saving Commodities for Women and Children \[[@B18]\].

However, this study found that many EmONC facilities in Afghanistan---including half of provincial, specialized, and regional hospitals---are continuing to administer diazepam to some patients with severe PE/E. The transition from using diazepam to using MgSO~4~ in the treatment of severe PE/E has lagged in many countries. Common obstacles include inappropriate policies, limited supplies, lack of training, and misperceptions about use of MgSO~4~\[[@B19]\]. A 2012 survey of 37 countries suggested that policy for and access to MgSO~4~ is improving, but that additional support is needed regarding provider competence and confidence in its use \[[@B20]\]. In Afghanistan, policy does not present a barrier to the use of MgSO~4~ because national guidelines exist and MgSO~4~ is included in the MoPH's Essential Drug List. Our findings indicate that supply is not a major problem either, given that the drug was in stock at nearly all assessed facilities. Rather, the case scenario suggests that confusion remains in the minds of many providers regarding the role of diazepam.

Training on the use of MgSO~4~---part of in-service EmONC training for midwives and doctors in Afghanistan---was associated with better decision-making on six items in the case scenario. However, training did not make a significant difference in providers' decisions on diazepam, in part because the EmONC training package identifies diazepam as an alternative drug for the management of severe PE/E when MgSO~4~ is not available. Two dozen other countries also have concurrent approval of diazepam and MgSO~4~ as first-line anticonvulsants, which present a potentially confusing scenario for health care providers \[[@B20]\]. Lack of understanding of how MgSO~4~ should be administered and persistent concerns about side effects, despite evidence of the drug's safety in low-resource settings, also contribute to providers' reluctance to administer the drug \[[@B21]\]. Further refresher training, accompanied by post-training follow-up, supportive supervision, consistent training manuals and job aids, is essential to help Afghan providers understand that MgSO~4~ is safe and should be preferred over diazepam whenever it is available. But studies suggest that training alone may not be sufficient to change providers' use of anticonvulsants. In Nepal, for example, a training intervention on severe PE/E raised providers' test scores, but they remained hesitant about administering MgSO~4~\[[@B22]\]. Without a ready supply of MgSO~4~, an easily accessible treatment protocol, supervision, and reinforcement of best practices after training, providers may not change established prescribing habits and switch from diazepam to MgSO~4~.

Low caseloads may blunt the impact of training, and sustaining competence with limited opportunities to practice is a challenge. In Zambia, for example, where lack of in-service training posed a barrier to the use of MgSO~4~, the infrequency of pre-eclampsia cases at small hospitals exacerbated the problem by limiting providers' exposure to the condition and opportunity to practice \[[@B23]\]. Our data suggest that this is potentially a problem at CHCs and district hospitals in Afghanistan, which may see only a handful of cases of severe PE/E each year. Providers working at smaller facilities also tend to have limited opportunities for learning and few, if any, colleagues to confer with. These disadvantages may explain why providers at CHCs and district hospitals scored significantly lower on five items in the clinical scenario. Providers at these facilities would benefit from regular refresher courses that include clinical simulations on severe PE/E, along with ready access to job aids, decision-making charts, and fully equipped emergency kits \[[@B24]\]. In Senegal, clinical audits of charts for all pregnant women with hemorrhagic and hypertensive complications also promoted correct diagnosis and treatment \[[@B25]\].

While providers scored well on many areas in the case scenario, there is room for improvement, especially in managing patients with eclampsia after convulsions are controlled. The need to strengthen knowledge on severe PE/E is not unique to Afghanistan: in an evaluation of skilled birth attendants in Benin, Ecuador, Jamaica, and Rwanda, mean knowledge scores for pregnancy-induced hypertension ranged from 52% to 78%. There was greater disparity in doctors' and midwives' knowledge of hypertension (75% and 58%, respectively) than their knowledge of other topics \[[@B26]\]. This finding stands in marked contrast to the situation in Afghanistan, where doctors and midwives had similar scores on the case scenario and shared the same strengths and weaknesses, with one exception (continuing to use anti-hypertensives to maintain diastolic pressure after convulsions are controlled). The similarity in the capacity of doctors and midwives is notable and somewhat unique. It may be due to the team approach to in-service EmONC training adopted by the MoPH, and increasingly common globally, which can help different health cadres understand each other's roles and promote greater collaboration and more effective teamwork \[[@B24]\].

While this study focuses on appropriate treatment of severe PE/E, reducing morbidity and mortality requires action outside of---and long before women arrive at---EmONC facilities. For example, calcium supplementation during pregnancy can prevent PE/E in countries like Afghanistan, where pregnant women get little calcium as part of their diet \[[@B7],[@B27]\]. Likewise, routinely screening for hypertension, proteinuria, and danger signs during ANC visits can detect cases of pre-eclampsia and prevent them from progressing to eclampsia \[[@B27]-[@B29]\]. Raising community awareness of warning signs of eclampsia, such as headache, visual disturbances, and epigastric pain, can prompt women to seek care in a timely manner \[[@B17],[@B30]\]. The weaknesses identified in the management of severe PE/E cases at EmONC facilities suggest that frontline health workers in Afghanistan may also suffer from limited knowledge, skills, and supplies. Further research on the capacity of community health workers who provide ANC in the community and at health posts in Afghanistan is needed to complement this study.

Study strengths and limitations
-------------------------------

This study used a case scenario to assess providers' capacity to manage severe PE/E cases. Clinical vignettes of this kind are a validated method to assess the quality of clinical practice that has been applied in both low- and high-income countries \[[@B31],[@B32]\]. They provide a simple and inexpensive way to assess how well providers apply knowledge and decision-making skills to realistically complex scenarios and have proven especially useful for comparing sites and settings. In this study, use of a case scenario permitted us to measure the impact of the facility setting and provider characteristics on case management.

Interpretation of the findings is subject to certain limitations. First, the assessment is not representative of the entire country, because security concerns limited the number and locations of facilities assessed. Second, the sampling strategy underrepresented providers at larger facilities who may have stronger skills, although fewer providers were selected from CHCs and district hospitals than provincial, regional, and specialized facilities. Third, no validity study has been conducted on the case scenario used in this assessment, although the tool was based on best practices. Fourth, it is not possible for a single case scenario to test providers' case management skills in a variety of situations as, for example, when a woman develops severe PE/E postpartum. Fifth, contradictions between different information sources, such as interviews and registers, suggest that data on services offered at each facility may be subject to recall and reporting bias.

Conclusions
===========

Drugs and supplies to treat severe PE/E are widely available at EmONC facilities in Afghanistan, but providers' knowledge is insufficient in some areas, especially regarding the decision to use MgSO~4~ instead of diazepam. Providers who have received specific training on PE/E or who work at larger facilities and who see more women with severe PE/E proved to have stronger case management skills. This suggests a need to: clarify service delivery guidelines, especially regarding anticonvulsants, and revise job aids and training materials accordingly; offer refresher training to providers who work at facilities with low caseloads; and reinforce best practices with supervision and other reinforcement activities. In particular, training efforts should place further emphasis on the superiority of MgSO4 over diazepam and on the need to continue antihypertensive treatment after delivery. The study findings will be used to help inform continuing education and reinforcement efforts in Afghanistan and also to standardize supplies and equipment across different facility levels. More broadly, they can contribute to the development of effective strategies for translating health worker knowledge into practice in low-income countries.
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